{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:48:24Z","timestamp":1791416904866,"version":"4.3.3"},"update-to":[{"DOI":"10.1002\/14651858.cd009132","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T00:00:00Z","timestamp":1347408000000}}],"reference-count":87,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009132.pub2","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T22:39:09Z","timestamp":1346798349000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Cholinesterase inhibitors for mild cognitive impairment"],"prefix":"10.1002","volume":"2016","author":[{"given":"Tom C","family":"Russ","sequence":"first","affiliation":[{"name":"University of Edinburgh; Division of Psychiatry; Kennedy Tower, Royal Edinburgh Hospital Morningside Terrace Edinburgh UK EH10 5HF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne R","family":"Morling","sequence":"additional","affiliation":[{"name":"University of Nottingham; Division of Epidemiology and Public Health; C120, Clinical Sciences Building - Ph2 City Hospital Campus, Hucknall Road Nottingham UK NG5 1PB"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"key":"10.1002\/14651858.CD009132.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/01.wnl.0000344650.95823.03","article-title":"Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial","volume":"72","author":"Doody","year":"2009","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1474-4422(07)70109-6","article-title":"Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study","volume":"6","author":"Feldman","year":"2007","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/153331750502000502","article-title":"Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study","volume":"20","author":"Koontz","year":"2005","journal-title":"American Journal of Alzheimer's Disease and Other Dementias"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-0404.2009.01263.x","article-title":"A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease","volume":"121","author":"Narasimhalu","year":"2010","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12603-012-0062-8","article-title":"A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI","volume":"16","author":"Peters","year":"2012","journal-title":"Journal of Nutrition, Health & Aging"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/01.WNL.0000134664.80320.92","article-title":"Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial","volume":"63","author":"Salloway","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/01.wnl.0000303815.69777.26","article-title":"Safety and efficacy of galantamine in subjects with mild cognitive impairment","volume":"70","author":"Winblad","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/01.wnl.0000303815.69777.26","article-title":"Safety and efficacy of galantamine in subjects with mild cognitive impairment","volume":"70","author":"Winblad","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/01.wnl.0000303815.69777.26","article-title":"Safety and efficacy of galantamine in subjects with mild cognitive impairment","volume":"70","author":"Winblad","year":"2008","journal-title":"Neurology"},{"issue":"8","key":"10.1002\/14651858.CD009132.pub2-BIB0011|cit11","first-page":"1","article-title":"Study of donepezil for MCI shows only minor improvement in patients with mild cognitive impairment","volume":"13","author":"Anon","year":"2009","journal-title":"Geriatric Psychopharmacology Update"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Barnes","year":"2005","journal-title":"\u00a0New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0013|cit13","first-page":"29","article-title":"Effect of rivastigmine in a double-blind study in MCI subjects: a functional magnetic resonance imaging study","volume":"11","author":"Bokde","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD009132.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1176\/jnp.2006.18.2.178","article-title":"Donepezil effects on cerebral blood flow in older adults with mild cognitive deficits","volume":"18","author":"Chen","year":"2006","journal-title":"Journal of Neuropsychiatry & Clinical Neurosciences"},{"issue":"18","key":"10.1002\/14651858.CD009132.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/WNL.0b013e3181bd6c25","article-title":"Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial","volume":"73","author":"Crane","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD009132.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"A191","DOI":"10.1016\/S1098-3015(10)74016-X","article-title":"Is genetic testing in combination with preventive donepezil (ARICEPT) treatment for patients with mild cognitive impairment cost-effective? (ISPOR 14th Annual International Meeting Orlando, FL United States)","volume":"12","author":"Djalalov","year":"2009","journal-title":"Value in Health"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD009132.pub2-BIB0017|cit17","first-page":"269","article-title":"Effects of donepezil on structural MRI and clinical markers in patients with amnestic mild cognitive impairment: a randomized, placebo-controlled trial (Alzheimer's Association International Conference on Alzheimer's Disease, Vienna)","volume":"5","author":"Dubois","year":"2009","journal-title":"Alzheimer's and Dementia"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0018|cit18","unstructured":"E2020-A001-412 A one year, multicenter, randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil hydrochloride in subjects with mild cognitive impairment (MCI), 2005 www.mrw.interscience.wiley.com\/cochrane\/clcentral\/articles\/394\/CN-00519394\/frame.html"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD009132.pub2-BIB0019|cit19","first-page":"332","article-title":"Effects of rivastigmine on brain white matter volume in mild cognitive impairment (MCI) (Alzheimer's Association International Conference on Alzheimer's Disease, Vienna)","volume":"5","author":"Ferris","year":"2009","journal-title":"Alzheimer's and Dementia"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0020|cit20","unstructured":"GAL-COG-3002 An analysis of mortality in subjects who participated in three studies of galantamine in mild cognitive impairment (MCI), 2005 clinicaltrials.gov\/ct2\/show\/NCT00297414"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0021|cit21","unstructured":"GAL-INT-11 A randomised placebo-controlled trial to evaluate the efficacy and safety of galantamine in patients with minimal cognitive impairment (MCI) clinically at risk for development of probable Alzheimer's disease, 2003 www.mrw.interscience.wiley.com\/cochrane\/clcentral\/articles\/132\/CN-00452132\/frame.html"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0022|cit22","unstructured":"GAL-INT-18 A randomized double-blind, placebo-controlled trial to evaluate the efficacy and safety of galantamine in subjects with mild cognitive impairment (MCI) clinically at risk for development of clinically probable Alzheimer's disease, 2004 www.mrw.interscience.wiley.com\/ cochrane\/clcentral\/articles\/227\/CN-00744227\/frame.html"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009132.pub2-BIB0023|cit23","first-page":"259","article-title":"Galantamine for the treatment of mild cognitive impairment: 2 double-blind, placebo-controlled studies","volume":"15","author":"Gold","year":"2003","journal-title":"International Psychogeriatrics"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0024|cit24","unstructured":"Grundman M MCI trial with vitamin E and donepezil. Proceedings of the 6th International Stockholm\/Springfield Symposium on Advances in Alzheimer Therapy, Stockholm, 2000 www.mrw.interscience.wiley.com\/cochrane\/clcentral\/articles\/212\/CN-00404212\/frame.html"},{"issue":"9","key":"10.1002\/14651858.CD009132.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.neurobiolaging.2007.03.004","article-title":"Longitudinal MRI findings from the Vitamin E and Donepezil Treatment Study for MCI","volume":"29","author":"Jack","year":"2008","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0026|cit26","unstructured":"Johnson & Johnson Pharmaceutical Research and Development A randomized double blind placebo-controlled trial to evaluate the efficacy and safety of galantamine in patients with mild cognitive impairment (MCI) clinically at risk for development of clinically probable Alzheimer's disease, 2005 clinicaltrials.gov\/ct2\/show\/NCT00236574"},{"issue":"1","key":"10.1002\/14651858.CD009132.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/gps.1038","article-title":"A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease","volume":"19","author":"Jones","year":"2004","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0028|cit28","first-page":"S128","article-title":"Efficacy of citicoline in the treatment of patients with vascular cognitive impairment (20th Meeting of the European Neurological Society, Berlin)","volume":"257","author":"Kopchak","year":"2010","journal-title":"Journal of Neurology"},{"issue":"24","key":"10.1002\/14651858.CD009132.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1212\/WNL.0b013e3181aa52d3","article-title":"Donepezil delays progression to AD in MCI subjects with depressive symptoms","volume":"72","author":"Lu","year":"2009","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2377-9-42","article-title":"Can cognitive enhancers reduce the risk of falls in older people with mild cognitive impairment? A protocol for a randomised controlled double blind trial","volume":"9","author":"Montero-Odasso","year":"2009","journal-title":"BMC Neurology"},{"issue":"5","key":"10.1002\/14651858.CD009132.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00002826-200309000-00008","article-title":"The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia","volume":"26","author":"Onofrj","year":"2003","journal-title":"Clinical Neuropharmacology"},{"issue":"1","key":"10.1002\/14651858.CD009132.pub2-BIB0032|cit32","first-page":"9","article-title":"Donepezil and vitamin E for mild cognitive impairment","volume":"8","author":"Ownby","year":"2006","journal-title":"Current Psychiatry Reports"},{"issue":"2","key":"10.1002\/14651858.CD009132.pub2-BIB0033|cit33","first-page":"62","article-title":"Efficacy of donepezil on cognitive functions in mild cognitive impairment","volume":"17","author":"Ozenli","year":"2007","journal-title":"Klinik Psikofarmakoloji Bulteni"},{"issue":"2","key":"10.1002\/14651858.CD009132.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1532-5415.2009.02702.x","article-title":"Effect of donepezil on the continuum of depressive symptoms, mild cognitive impairment, and progression to dementia","volume":"58","author":"Panza","year":"2010","journal-title":"Journal of the American Geriatrics Society"},{"issue":"9","key":"10.1002\/14651858.CD009132.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMc051856","article-title":"\"Vitamin E and donepezil for the treatment of mild cognitive impairment\": the authors reply","volume":"353","author":"Petersen","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009132.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3174\/ajnr.A1359","article-title":"Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging","volume":"30","author":"Petrella","year":"2009","journal-title":"American Journal of Neuroradiology"},{"issue":"1","key":"10.1002\/14651858.CD009132.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0033-3182(10)70665-4","article-title":"Improvement of cognitive dysfunction with high-dose rivastigmine","volume":"51","author":"Politis","year":"2010","journal-title":"Psychosomatics"},{"issue":"7","key":"10.1002\/14651858.CD009132.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/brain\/awh177","article-title":"Cholinergic enhancement of frontal lobe activity in mild cognitive impairment","volume":"127","author":"Saykin","year":"2004","journal-title":"Brain"},{"issue":"12","key":"10.1002\/14651858.CD009132.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1001\/archneur.61.12.1852","article-title":"Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial","volume":"61","author":"Seltzer","year":"2004","journal-title":"Archives of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD009132.pub2-BIB0040|cit40","first-page":"35","article-title":"Donepezil in the treatment of age-acquired cognitive deficit","volume":"9","author":"Shua-Haim","year":"2001","journal-title":"Clinical Geriatrics"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0041|cit41","first-page":"421","article-title":"Tolerance and adverse events of treatment with acetylcholinesterase inhibitors in a clinical sample of patients with very slight and mild Alzheimer's disease over a six-month period","volume":"36","author":"Turon-Estrada","year":"2003","journal-title":"Revista de Neurologia"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0042|cit42","doi-asserted-by":"crossref","unstructured":"Vandesquille M Chauveau F Decros-Tesolin B Pierard C Sebban S Mouthon F Potentiation of donepezil efficiency profile by connexin inhibitors in age-related cognitive impairment European Neuropsychopharmacology Conference: 2012 ECNP Workshop on Neuropsychopharmacology for Young Scientists in Europe, Nice, France 2012","DOI":"10.1016\/S0924-977X(12)70046-9"},{"issue":"10","key":"10.1002\/14651858.CD009132.pub2-BIB0043|cit43","first-page":"760","article-title":"An interventional study on amnestic mild cognitive impairment with small dose donepezil","volume":"43","author":"Wang","year":"2004","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archneurol.2009.292","article-title":"Donepezil treatment and changes in hippocampal structure in very mild Alzheimer disease","volume":"67","author":"Wang","year":"2010","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD009132.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"P288","DOI":"10.1093\/geronb\/63.5.P288","article-title":"Acetylcholinesterase inhibitor in combination with cognitive training in older adults","volume":"63B","author":"Yesavage","year":"2008","journal-title":"Journals of Gerontology Series B: Psychological Sciences & Social Sciences"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0046|cit46","unstructured":"24-week, randomized, double-blind, placebo-controlled, parallel group study of the Exelon\u00ae [rivastigmine] transdermal patch in 120 APOE e4 positive amnestic MCI patients, 2011 http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01602198"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/ageing\/27.3.399","article-title":"The clock-drawing test","volume":"27","author":"Agrell","year":"1998","journal-title":"Age and Ageing"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer's & Dementia"},{"issue":"1","key":"10.1002\/14651858.CD009132.pub2-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009132.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001190.pub2","article-title":"Donepezil for dementia due to Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009132.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001191.pub2","article-title":"Rivastigmine for Alzheimer's disease","author":"Birks","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0052|cit52","article-title":"British National Formulary No. 63","volume-title":"British National Formulary, 63rd Edition","author":"British Medical Association and the Royal Pharmaceutical Society of Great Britain","year":"March 2012"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological Stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathologica"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0054|cit54","volume-title":"Color Trails Test: Professional Manual","author":"D'Elia","year":"1996"},{"issue":"7","key":"10.1002\/14651858.CD009132.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/gps.930070704","article-title":"Concepts of mild memory impairment in the elderly and their relationship to dementia - a review","volume":"7","author":"Dawe","year":"1992","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00406-008-0864-1","article-title":"To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer\u2019s disease","volume":"259","author":"Diniz","year":"2009","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-Mental State\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009132.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer\u2019s disease. The Alzheimer\u2019s Disease Cooperative Study","volume":"11","author":"Galasko\u00a0D","year":"1997","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(06)68542-5","article-title":"Mild cognitive impairment","volume":"367","author":"Gauthier","year":"2006","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/0957154X06061600","article-title":"V. A. Kral, the Montreal Hebrew Old People's Home, and benign senescent forgetfulness","volume":"17","author":"Heinik","year":"2006","journal-title":"History of Psychiatry"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1017\/S1041610209991682","article-title":"V. A. Kral and the origins of benign senescent forgetfulness and mild cognitive impairment","volume":"22","author":"Heinik","year":"2010","journal-title":"International Psychogeriatrics"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0063|cit63","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0064|cit64","unstructured":"Johnson & Johnson Pharmaceutical Research & Development L.L.C An analysis of mortality in subjects who participated in three studies of galantamine in mild cognitive impairment CR004240"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/089198879901200402","article-title":"Neuropsychological prediction of decline to dementia in non-demented elderly","volume":"12","author":"Kluger","year":"1999","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0066|cit66","volume-title":"Neuropsychological Assessment","author":"Lezak","year":"2004"},{"issue":"1","key":"10.1002\/14651858.CD009132.pub2-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001747.pub3","article-title":"Galantamine for Alzheimer's disease and mild cognitive impairment","author":"Loy","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD009132.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD009132.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging - Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer's & Dementia"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009132.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00002093-199700112-00003","article-title":"Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer\u2019s Disease Assessment Scale that broaden its scope. The Alzheimer\u2019s Disease Cooperative Study","volume":"11","author":"Mohs","year":"1997","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0073|cit73","article-title":"Mild cognitive impairment","volume-title":"Oxford Textbook of Old Age Psychiatry","author":"O'Brien","year":"2008"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0074|cit74","volume-title":"Key Population and Vital Statistics","author":"Office for National Statistics","year":"2006"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0075|cit75","first-page":"326","article-title":"Normal aging, mild cognitive impairment, and early Alzheimer's disease","volume":"1","author":"Petersen","year":"1995","journal-title":"Neurologist"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archneur.63.5.665","article-title":"Neuropathologic features of amnestic mild cognitive impairment","volume":"63","author":"Petersen","year":"2006","journal-title":"Archives of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD009132.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1371\/journal.pmed.0040338","article-title":"Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials","volume":"4","author":"Raschetti","year":"2007","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000096295","article-title":"Subjective memory complaints and cognitive impairment in older people","volume":"22","author":"Reid","year":"2006","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0080|cit80","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"401","DOI":"10.31887\/DCNS.2004.6.4\/kritchie","article-title":"Mild cognitive impairment: an epidemiological perspective","volume":"6","author":"Ritchie","year":"2004","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD009132.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD009132.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD009132.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/brain\/111.3.695","article-title":"A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease","volume":"111","author":"Sahakian","year":"1988","journal-title":"Brain"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009132.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Schneider","year":"1997","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0086|cit86","first-page":"13","article-title":"Cholinesterase Inhibitors in mild cognitive impairment: a meta-analysis of randomized controlled trials","volume":"41","author":"Sob\u00f3w","year":"2007","journal-title":"Neurologia i\u00a0Neurochirurgia Polska"},{"key":"10.1002\/14651858.CD009132.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"Journal of Internal Medicine"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009132.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T09:36:34Z","timestamp":1690968994000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009132.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":87,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009132.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,12]]}}}